We are live on ! Find out more
JPMIA

J.P. Marvel Investment Advisors Portfolio holdings

AUM $705M
1-Year Est. Return 43.01%
This Fund
S&P 500
This Quarter Est. Return
+12.64%
1 Year Est. Return
+43.01%
3 Year Est. Return
+140.86%
5 Year Est. Return
+213.54%
10 Year Est. Return
AUM
$387M
AUM Growth
+$39.3M
Cap. Flow
+$1.14M
Cap. Flow %
0.29%
Top 10 Hldgs %
42.25%
Holding
70
New
2
Increased
17
Reduced
11
Closed

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$403K
2
AMZN icon
Amazon
AMZN
+$86.2K
3
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$70.8K
4
TMO icon
Thermo Fisher Scientific
TMO
+$37.5K
5
AAPL icon
Apple
AAPL
+$32.5K

Sector Composition

Rank Sector Weight
1 Healthcare 29.84%
2 Technology 25.15%
3 Financials 13.21%
4 Communication Services 8.83%
5 Consumer Discretionary 6.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.97T
$28.7M 7.41%
216,153
-270
-0.1% -$32.5K
AMZN icon
2
Amazon
AMZN
$2.44T
$21.8M 5.62%
133,580
-540
-0.4% -$86.2K
TMO icon
3
Thermo Fisher Scientific
TMO
$214B
$18.3M 4.72%
39,220
-80
-0.2% -$37.5K
GOOGL icon
4
Alphabet (Google) Class A
GOOGL
$4.12T
$18.1M 4.69%
206,860
+960
+0.5% +$80.8K
MS icon
5
Morgan Stanley
MS
$319B
$14.4M 3.73%
210,767
+8,680
+4% +$498K
JPM icon
6
JPMorgan Chase
JPM
$916B
$14.2M 3.67%
111,622
+125
+0.1% +$14K
V icon
7
Visa
V
$701B
$14M 3.61%
63,802
+200
+0.3% +$40.9K
NVDA icon
8
NVIDIA
NVDA
$4.6T
$11.8M 3.05%
905,000
+2,000
+0.2% +$26.8K
BMY icon
9
Bristol-Myers Squibb
BMY
$129B
$11.3M 2.93%
182,438
+1,229
+0.7% +$75.6K
JNJ icon
10
Johnson & Johnson
JNJ
$640B
$10.9M 2.82%
69,346
+195
+0.3% +$28.8K
LLY icon
11
Eli Lilly
LLY
$1.08T
$9.66M 2.5%
57,243
GLW icon
12
Corning
GLW
$107B
$9.18M 2.37%
255,121
+1,160
+0.5% +$41.2K
AKAM icon
13
Akamai
AKAM
$15.6B
$9.11M 2.35%
86,767
-210
-0.2% -$22K
MSFT icon
14
Microsoft
MSFT
$2.9T
$9.07M 2.34%
40,787
BAC icon
15
Bank of America
BAC
$429B
$8.54M 2.21%
281,624
ABBV icon
16
AbbVie
ABBV
$465B
$8.36M 2.16%
78,030
+650
+0.8% +$62.5K
CRL icon
17
Charles River Laboratories
CRL
$11.3B
$8.32M 2.15%
33,314
+104
+0.3% +$24.8K
CSCO icon
18
Cisco
CSCO
$443B
$8.29M 2.14%
185,343
LRCX icon
19
Lam Research
LRCX
$316B
$8.12M 2.1%
171,860
DE icon
20
Deere & Co
DE
$165B
$7.91M 2.05%
29,406
ABT icon
21
Abbott
ABT
$188B
$7.76M 2.01%
70,891
PFE icon
22
Pfizer
PFE
$143B
$7.4M 1.91%
200,920
-10,990
-5% -$403K
AWK icon
23
American Water Works
AWK
$27B
$7.38M 1.91%
48,111
-90
-0.2% -$13.9K
CVS icon
24
CVS Health
CVS
$135B
$7.24M 1.87%
105,995
+2,915
+3% +$190K
MRNA icon
25
Moderna
MRNA
$21.6B
$6.87M 1.78%
65,745

Similar funds

J.P. Marvel Investment Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, J.P. Marvel Investment Advisors held 70 positions worth $387M, up 11% from $348M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Trading was light in Q4 2020: portfolio turnover was 2.9%. J.P. Marvel Investment Advisors opened 2 new positions and made no exits, leaving the 70-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 30% a quarter earlier, followed by Technology and Financials.

  • J.P. Marvel Investment Advisors's largest Q4 2020 buy was Viatris: 24,908 shares worth $467K.
  • J.P. Marvel Investment Advisors added most to Morgan Stanley in Q4 2020, an estimated $498K increase.
  • J.P. Marvel Investment Advisors's biggest Q4 2020 reduction was Pfizer, cutting an estimated $403K.
  • J.P. Marvel Investment Advisors's ten largest holdings make up 42% of its $387M portfolio in Q4 2020.
  • J.P. Marvel Investment Advisors opened 2 new positions and closed 0 in Q4 2020.
  • J.P. Marvel Investment Advisors's portfolio value rose 11% quarter-over-quarter to $387M.

Based on J.P. Marvel Investment Advisors's 13F filing for Q4 2020, filed 9 Sep 2021.